FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortage
June 01, 2023 at 14:43 PM EDT
Shortages of cisplatin and carboplatin, bedrock cancer treatments, have forced some hospitals to ration the drugs.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
